“Barely in its infancy, the CBD medical market is still largely unregulated; quality control is meager at best, and consumers are largely unaware what to look for when shopping …,” explains Carlos Frias of the Texas Wellness Center. Frias, who has been with the cannabis industry for more than 15 years, has seen, firsthand, the shadiness that exists in the CBD market.
While researchers are calling for more robust studies on the role of CBD on mood disorders, there is promising research that points to CBD’s role as an anxiolytic – which means it has anti-anxiety effects. Another study showed CBD to have antidepressant effects comparable to those of the prescription antidepressant Imipramine. We noted above that CBD increases levels of glutamate and serotonin – and it’s these same neurotransmitters that play a crucial role in mood regulation.